Search:
 
Home > AIM > Company Profiles > Abcam

Price

Market

Sector

Market Cap
447.50p (2.50p) 0.56% Up AIM Retailers £156.56m
Add to company folder | Print
Articles Financial Data Charts Profile
Related Companies

Commentary

Research-grade antibodies producer & marketer via its own online catalogue

Recent Articles

Abcam 09/07/2008
Directors’ Dealings 31/03/2008
Abcam 10/03/2008

Recent Announcements

Notice of Results
 21/08/2008
Year-end Trading Update
 09/07/2008
Shareholding
 02/07/2008
Grant of Share Options
 07/05/2008
Trading Update
 01/05/2008
Shareholding
 29/04/2008
Director's Dealings
 02/04/2008
Shareholding
 26/03/2008
Transfer of Shares
 20/03/2008
Shareholding
 17/03/2008
More

Articles from the Sector

H&T Group 20/08/2008
Southern Bear plans £7.5m takeover 06/08/2008
H&T: high growth, highly defensive 05/08/2008
Retail 04/08/2008
‘Clicks and mortar’ approach to retail 30/06/2008
EBTM 20/06/2008
Ideal Shopping Direct 13/06/2008
Stuffing knocked out of ScS 12/06/2008
ScS Upholstery 28/05/2008
Researcher forges LSE link
 19/05/2008
More

Financial History
Financial Year End 30/06/2005 30/06/2006 30/06/2007
Currency GBP GBP GBP
Turnover 12.14 19.36 24.52
Operating Profit 2.92 4.51 5.21
Pretax Profit 2.98 4.83 5.70
Earnings After Tax 2.28 3.42 4.15
Profit Available For Dividend 0.00 0.00 0.00
Ordinary Dividends -1.32 0.00 0.00
Retained Profit 2.28 3.42 4.15
Shareholders Funds 3.21 15.07 18.43
Net Current Assets 2.46 13.98 14.73
Adjusted Earnings Per Share Undiluted 8.59 10.73 11.99
Adj Earnings Per Share 7.59 10.36 11.67
Dividend Per Share 4.79 2.70 3.99

Company Details

Address 332 Cambridge Science Park, Milton Road, Cambridge, CB4 OFW
Telephone 01223 696 000
Fax 01223 696 001

Executives

Chairman David Cleevely (10.20% holding)
Chief Executive Jonathan Milner (23.00% holding)
Finance Director Jeffrey Iliffe (0.00% holding)
Managing Director David Warwick (2.40% holding)

Main Shareholders

N W Brown Nominees: 12.4%
Unicorn Asset Management: 6.8%
Artemis Investment Management: 6.3%
Morley Fund Management: 5.6%

Advisers

Nominated Adviser Numis
Nominated Broker Numis
Solicitors Eversheds
Auditors Deloitte
Registrar Capita Registrars

Commentary

Research-grade antibodies producer & marketer via its own online catalogue

Company Data
Code ABC
Sedol GB00B0LWCX
Shares In Issue 34.986 m
Indices
Entry on AIM 03/11/2005
Interim Results Mar
Final Results Sep
Year End Jun
Accounts Due Dec
Int div payment Apr
Fin div payment Dec
Int net div per share 3.19
Fin net div per share 1.04
Probable CGT relief Yes